What is King Pharmaceuticals's workers' compensation — year 8?

King Pharmaceuticals (KG) reported workers' compensation — year 8 of 1.7% in Q4 2025.

What does workers' compensation — year 8 mean?

This metric quantifies the financial output of the Workers' Compensation insurance product line for the eighth year. It provides insight into how the company manages underwriting cycles and claims exposure within this specialized insurance market.

King Pharmaceuticals KG Workers' Compensation — Year 8

Other product segments

General Liability

6.4%—

European Hospital Liability

5%—

Commercial Auto Liability

2.3%—

All other lines

0.1%—

International

-0.1%—

Similar metrics at other companies

CNAWorkers' Compensation — Year 8

1.2%0.0pp

ORIWorkers' Compensation — Year 8

1.2%-0.2pp

HIGWorkers' Compensation — 8th Year

2.1%0.0pp

UFCSCommercial workers' compensation — Year 8

1.1%+0.1pp

ORIWorkers' Compensation — Year 7

2%0.0pp

CNAWorkers' Compensation — Year 7

2.3%0.0pp

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:ShortdurationInsuranceContractsHistoricalClaimsDurationYearEight.

The official record: King Pharmaceuticals’s 10-K, filed March 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's workers' compensation — year 8.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's workers' compensation — year 8?: King Pharmaceuticals (KG) reported workers' compensation — year 8 of 1.7% in Q4 2025.
What does workers' compensation — year 8 mean?: This metric quantifies the financial output of the Workers' Compensation insurance product line for the eighth year. It provides insight into how the company manages underwriting cycles and claims exposure within this specialized insurance market.